publication venue for
- Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study. 57:232-244. 2024
- Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study. 55:297-303. 2022
- Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. 54:225-231. 2021
- Platelet α2-Adrenergic Receptors in Depressed Patients and Healthy Volunteers: The Effects of Desipramine. 25:199-206. 1992